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Abstract
Background: Recently, we demonstrated that human mesenchymal stem cells (hMSC) stimulated
with dexamethazone undergo gene focusing during osteogenic differentiation (Stem Cells Dev 14(6):
1608–20, 2005). Here, we examine the protein expression profiles of three additional populations
of hMSC stimulated to undergo osteogenic differentiation via either contact with pro-osteogenic
extracellular matrix (ECM) proteins (collagen I, vitronectin, or laminin-5) or osteogenic media
supplements (OS media). Specifically, we annotate these four protein expression profiles, as well
as profiles from naïve hMSC and differentiated human osteoblasts (hOST), with known gene
ontologies and analyze them as a tensor with modes for the expressed proteins, gene ontologies,
and stimulants.
Results: Direct component analysis in the gene ontology space identifies three components that
account for 90% of the variance between hMSC, osteoblasts, and the four stimulated hMSC
populations. The directed component maps the differentiation stages of the stimulated stem cell
populations along the differentiation axis created by the difference in the expression profiles of
hMSC and hOST. Surprisingly, hMSC treated with ECM proteins lie closer to osteoblasts than do
hMSC treated with OS media. Additionally, the second component demonstrates that proteomic
profiles of collagen I- and vitronectin-stimulated hMSC are distinct from those of OS-stimulated
cells. A three-mode tensor analysis reveals additional focus proteins critical for characterizing the
phenotypic variations between naïve hMSC, partially differentiated hMSC, and hOST.
Conclusion: The differences between the proteomic profiles of OS-stimulated hMSC and ECM-
hMSC characterize different transitional phenotypes en route to becoming osteoblasts. This
conclusion is arrived at via a three-mode tensor analysis validated using hMSC plated on laminin-5.
Background
Interest in human stem cells continues to grow amongst
those interested in understanding fundamental mecha-
nisms of development and disease progression and those
interested in harnessing the differentiation potential of
these cells to generate living replacements for damaged or
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diseased tissues. In both cases, the promise is the same:
stem cells offer the potential to define and manipulate
fundamental principles of cell and tissue behavior, which
in turn will uncover a new set of therapeutic targets for
correcting errors in cell and tissue function [1]. Human
mesenchymal stem cells (hMSC) are a population of
multipotent adult cells found within the bone marrow
and periosteum [2] and capable of differentiating into as
many as seven different cell types [3].
One bottleneck in the development of hMSC-derived
therapies is our incomplete understanding of the mecha-
nisms governing hMSC differentiation. For example, oste-
oblast differentiation from bone marrow progenitor cells
(such as hMSC) has been described as a series of up to
seven overlapping stages, each defined by a change in
gene expression patterns [4]. Other studies suggest that
these stages are a continuum, rather than distinct events
[5-7]. Further complicating matters, hMSC committed to
an osteogenic phenotype via treatment with dexameth-
azone retain the ability to transdifferentiate into other lin-
eages [8]. Distinct patterns defining osteogenic
differentiation of these cells have yet to emerge [9],
though we and others have identified significant signaling
and gene expression changes during osteogenic differenti-
ation of hMSC [3,9-14].
To gain a better understanding of hMSC osteogenic differ-
entiation, we previously used gene ontology analysis of
protein expression profiles from hMSC, human osteob-
lasts (hOST), and hMSC stimulated to undergo osteogenic
differentiation with osteogenic stimulant (OS) media
containing ascorbic acid-2-phosphate, β-glycerophos-
phate, and the synthetic glucocorticoid, dexamethazone
[15]. Our analysis revealed that OS-induced differentia-
tion results in a decrease in the number of mesenchymal
cell markers and calcium-mediated signaling molecules
with a concomitant increase in expression of specific
extracellular matrix molecules and their receptors, a proc-
ess we call "gene focusing." [15,16] Second, we found that
the protein expression profile of OS-induced hMSC par-
tially overlapped with the profiles of both naïve hMSC
and hOST, suggesting that OS-stimulated hMSC represent
an "intermediate state" during osteogenic differentiation
of hMSC. These results strongly imply that changes in the
extracellular matrix (ECM) in the hMSC microenviron-
ment have a direct impact on stem cell differentiation.
It is well known that ECM proteins, along with growth fac-
tors and hormones, play key roles during bone develop-
ment. For example, during endochondral bone
development, collagen II expression peaks during the
chondrogenesis period while collagen I deposition is
maximal during the ossification phase [17]. For decades it
has been known that single point mutations in collagen I
yield a lethal form of osteogenesis imperfecta (e.g., [18]).
Genetic knockout of collagen II results in embryonic
lethality associated with severe skeletal defects [19]. In
vitro, hMSC undergo osteogenic differentiation when cul-
tured on collagen I, fibronectin, vitronectin, or laminin-5
matrices [11,13,20], and this requires ECM interaction
with specific integrin receptors [11,13,21,22]. A recent
study demonstrates that osteogenic commitment of
hMSC is irreversible after three weeks in culture on colla-
gen I [10] but osteogenic differentiation induced by dex-
amethazone gradually diminishes in the absence of
collagen I over the same time course [9]. These results sug-
gest that stimulation of hMSC with dexamethazone and
collagen I (or other ECM proteins) could induce osteo-
genic differentiation through different mechanisms and
that these differences could be detected in the protein pro-
files of these different populations.
To test this idea, we used tensor analysis of protein expres-
sion profiles, annotated with gene ontologies, to uncover
protein expression changes during the progression of
stimulated hMSC towards fully differentiated hOST that
distinguish distinct intermediary states of OS-hMSC and
ECM-hMSC. Our results support the conclusion that OS-
and ECM-induced hMSC are distinct intermediate states
during osteogenic differentiation, and demonstrate that
stimulation with the ECM proteins collagen I, vitronectin,
and laminin-5 results in a more osteoblast-like phenotype
than does stimulation with OS media.
Results
To identify the proteins expressed by osteogenic differen-
tiation of hMSC arising from stimulation with OS media
and two ECM proteins (collagen I and vitronectin) and
compare them to the protein expression profiles of undif-
ferentiated hMSC; hMSC stimulated by OS media; and
physiologically differentiated hOST, we performed 2D
LC-MS/MS on whole-cell lysates of these cell populations.
758 distinct proteins indicated by an Entrez gene ID
(GeneID) were identified by 2D LC-MS/MS in all five cell
populations (= 200 pmol). To validate the approach, we
also examined the expression of these 758 distinct pro-
teins in hMSC stimulated by laminim-5 (Ln-5). To evalu-
ate the functional significance of these differences, we
accessed the GO (Gene Ontology) Chart featured by
DAVID to identify significant GO Biological Process and
Molecular Function categories for each of the 5 original
samples and unioned them to form a set of 69 GO catego-
ries (provided in Additional File 1). Thus the data form a
tensor or datacube with three modes: the first being 6
experiments, the second being the 758 GeneIDs, and the
third being the 69 GOs. Each entry of the tensor contains
a 0 if no proteins were found, 1 if exactly one protein was
found, or 2 if multiple proteins were found corresponding
to a given (sample, GeneID, GO) triplet. We developedBMC Genomics 2007, 8:380 http://www.biomedcentral.com/1471-2164/8/380
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two-way and three-way approaches for analyzing the
(sample, geneID, GO) tensor. We begin with discussion of
the results of the two-way approach.
Two-way analysis
The two-way approach first reduces the three-mode tensor
to a two-dimensional matrix in the (sample, GO) space
and then uses a variation of the widely-used Principal
Component Analysis (PCA) method in this space. Typi-
cally one would see PCA used for genomics in the equiva-
lent of the (sample, geneID) space. Traditional PCA
centers the data about the mean and then finds the series
of orthogonal components that best explain the variance
of the data [23]. Our novel approach reduces the data to a
(sample, GO) matrix, transforms the data to make undif-
ferentiated hMSC the origin, and then directs or forces the
first component to be the difference between hOST and
hMSC in the GO space. The remaining components are
selected to maximize the explanation of the remaining
variability subject to the constraint that they be uncorre-
lated (orthogonal) with each other and with the directed
component. We call this approach to modeling Directed
Component Analysis (DCA), differing from Principal Compo-
nent Analysis in that the offset and directed vectors are cho-
sen based on biological process intuition as opposed to
the mean vector and leading principal component, respec-
tively.
The GO proteomic profiles of each of the samples are pro-
jected onto the DCA component space spanned by the
first three components to provide clear insight into the
distinct states of the three types of sample. To validate the
hypotheses that ECM stimulated hMSC (ECM-hMSC)
evoke similar intermediate differentiation states, we
reserve one of the ECM samples – hMSC stimulated with
laminin-5 (ln5-hMSC) – as a test sample. The compo-
nents of DCA are constructed using only five samples:
hMSC, vintronectin stimulated hMSC (vn-hMSC), colla-
gen 1 stimulated hMSC (col1-hMSC), OS-hMSC, and
hOST. The directed component accounts for 26% of the
variability while the second, third, and fourth compo-
nents account for 41%, 22%, and 10% of the variability,
respectively, in the first five samples. The fourth compo-
nent is largely noise and thus is discarded. Thus each sam-
ple is transformed to a three dimensional representation.
The first directed component is the direction that connects
hMSC to hOST. For each experiment, cdirected is the extent
to which the experiment is similar to osteoblast along this
route. These constants are plotted in Figure 1, providing
an implicit ranking of experiments. We can see that stim-
ulated hMSC fall on a spectrum from hMSC to hOST.
We also see that the three ECM-stimulated samples cluster
together including the validation sample, ln5-hMSC,
which was not used to construct the components. In gen-
eral the ECM-stimulated hMSC tend to more closely
resemble osteoblasts than do the OS media-stimulated
hMSC. Thus, the first directed component provides a char-
acterization of how "osteoblast-like" the samples are. The
two remaining components capture how the samples vary
from the directed path between hMSC and hOST. The
coefficients for each experiment may be plotted against
each other, as in Figure 2. By construction of the directed
component, the further right a population falls the closer
it is to hOST. The second component plotted as the verti-
cal axis in Figure 2 (left) shows that ECM-hMSC and
hOST-hMSC form two distinct intermediate states. The
ECM-hMSC cluster together at the top of the graph, mean-
ing that they are fairly similar in many respects. OS-hMSC
appears at the bottom of the plot, far from the ECM-hMSC
samples. The plot shows that the ECM-hMSC and OS-hMSC
achieve distinct intermediate states along the lineage from stem
cells to Osteoblasts. Figure 2 (right) plots the third compo-
nent versus the directed component. Here we see that the
stimulated hMSC samples fall together and third compo-
nent characterizes the variability within the intermediate
states. Together the plots suggest that the stimulated
hMSC represent two distinct lineages along the path from
hMSC to hOST.
An interesting question is what categories have the great-
est impact on the cell differentiation process. Figure 3
plots weights for these categories in the directed and sec-
ond components plane. Categories near the center of the
Directed Component scores Figure 1
Directed Component scores. The directed component 
score ranks the samples (experiments) from stem cells to 
osteoblasts.BMC Genomics 2007, 8:380 http://www.biomedcentral.com/1471-2164/8/380
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cluster (indicated by a small red circle) have little impact
on the experiments, while those far from the center (and
in particular outside of the circle of double standard devi-
ation) are critical for osteogenesis.
From Figure 3, we can see that the following categories
primarily characterize the route from hMSC to hOST: 20
(cytokine activity), 27 (heparin binding), 46 (oxygen and
reactive oxygen species metabolism), 52 (protein kinase
activity), and 69 (translation initiation factor activity).
The following categories primarily distinguish between
the OS- and ECM-stimulated intermediary states: 43 (oxi-
doreductase activity, acting on peroxide as acceptor), 44
(oxidoreductase activity, acting on single donors with
incorporation of molecular oxygen), 45 (oxidoreductase
activity, acting on the ch-ch group of donors), categories
39 (organismal movement) and 4 (amino acid and deriv-
ative metabolism). Categories 52 (protein kinase activity)
and 27 (heparin binding) are important for characterizing
both the transition from hMSC to hOST and the differ-
ences between the two intermediate states. Repeating this
analysis with the second and third components identifies
two additional GOs: 12 (cation transporter activity) and
42 (oxidoreductase activity, acting on paired donors, with
incorporation or reduction of molecular oxygen). The
proteins in this set of 12 GOs (given in Additional File 2,
Directed Component plots of hMSC, hOST, and stimulated stem cells Figure 2
Directed Component plots of hMSC, hOST, and stimulated stem cells. Directed Component plots of hMSC, hOST, 
and stimulated stem cells demonstrate distinct lineages of ECM-hMSC vs. OS-hMSC.
Weights on the GOs for the directed and second compo- nents Figure 3
Weights on the GOs for the directed and second 
components. Weights on the GOs are plotted for the 
directed and second components. GOs falling outside the 
circle of standard deviation are critical for the components.BMC Genomics 2007, 8:380 http://www.biomedcentral.com/1471-2164/8/380
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Directed Component Analysis Spreadsheet) provide a set
of potential biomarkers of interest. Analysis of this set of
proteins is provided in the discussion section.
Three-way analysis
In this section, our goal is to identify a set of significant
GeneIDs and to capture the structure within that set, tak-
ing into consideration in which categories and samples
they are present. While insightful for visualization and
general trends, the two-way analysis of the (Samples, GO)
data involves a loss of information that limits the infor-
mation revealed regarding relevant GeneIds. The DCA
analysis will miss critical proteins that fall outside of the
13 categories identified. Multiway analysis fully preserves
the three-way nature of the data (GeneIDs, Categories,
and Samples).
The Tucker3 [24] analysis was used to determine compo-
nents for each of the three modes: Sample, GeneID, and
GO. The tensor was preprocessed in the same way as in the
two-way analysis: by truncating the number of proteins in
each entry to at most two and by transforming the data to
make hMSC the origin. We make use of the results pro-
vided by two-way analysis to determine the number of
components to be extracted from each mode in the
Tucker3 model. Component numbers are chosen such
that the relationship observed in the sample mode coin-
cides with the results of two-way analysis of the Samples x
Categories matrix. We select components in the Category
mode that best model the categories considered signifi-
cant in capturing the structure in Samples mode (those
having high-loading coefficients). Then core elements are
inspected in order to identify the components in GeneID
mode whose interaction with selected components in
other modes is represented with high core values. Finally,
we examine the scatter plot of the selected components
(the first and third components have highest core value)
in GeneID mode to understand the structure among
GeneIDs. Figure 4 illustrates GeneIDs projected onto the
space spanned by the first and third components of the
GeneID mode. We are particularly interested in the out-
liers detected through loading coefficients. A set of 23 out-
lier GeneIDs, detected through both thresholding and
statistical confidence testing, is marked in Figure 4. A table
containing these proteins can be found in Additional File
3, Tensor Analysis Spreadsheet.
When we study the selected GeneIDs closely, we observe
that two underlying principles govern how they spread
around the plot: Samples and Categories. For instance,
some outlier GeneIDs, e.g. {815, 816, 817, 818, 7170,
10342, 23043}, cluster together in the first quadrant. That
is because they not only exist in the same samples (mostly
Sample 1 – hMSC) but also share significant categories,
i.e. Protein Kinase Activity, Transferase Activity, Transfer-
ring Phosphorus-containing Groups, etc. On the other
hand, some GeneIDs are farther apart from each other if
they differ in either categories or samples mode. For exam-
ple, GeneIDs 529 and 539 are available in exactly the
same categories but they differ in the samples in which
they are present. Therefore, one of them is in the second
quadrant while the other is in the fourth in Figure 4.
Discussion
Undifferentiated hMSC, ECM-hMSC, OS-hMSC, and fully
differentiated hOST express many proteins in common,
yet each population also expresses distinct sets of pro-
teins. We believe these differences allow us to discrimi-
nate between different degrees of osteogenic
differentiation in hMSC, and suggest possible mecha-
nisms for how osteogenic differentiation occurs in these
cells. To provide additional information to offset the low
sample size, we performed the analysis in the GO space.
Our DCA established a "differentiation axis" that allows
us to rank and compare intermediate states of osteogenic
differentiation. This axis represents the vector accounting
for the greatest variance between hMSC and hOST and
gives us a new tool to uncover protein/gene expression
differences that may be related to stem cell and osteoblast
function. Tensor analysis in the (sample, GO, GeneID)
space was used to further elucidate proteins critical for dif-
ferentiation. Our approach is entirely different from, and
complimentary to, more traditional comparative methods
such a DNA microarray, SAGE, and EST sequence analysis
[25-28]. The addition of gene ontology to the data tensor
Scatter plot of GeneIDs Figure 4
Scatter plot of GeneIDs. 361 GeneIDs are projected onto 
the space spanned by the first and third components in 
GeneID mode. Red color and diamond shape are used to 
indicate the GeneIDs considered significant and examined 
closely. The rest of the GeneIDs have comparatively low 
loading coefficients and areconsidered insignificant.
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provides a critical difference between our approach and
the now standard Principal Component Analysis (PCA)
and more recent tensor analysis [29] for gene expression
data.
Our differentiation axis begins with undifferentiated stem
cells. The DCA and tensor analyses identified at least 20
proteins expressed in undifferentiated hMSC, but not in
hOST, that may help define the activities of undifferenti-
ated or partially differentiated stem cells. Some of these,
such as the eukaryotic translation factors (EIF2, EIF4,
EIF5), histone H4i, the lysosomal proteon pump
ATP6V1E1, the peroxisomal biogenesis factor 6, asparag-
ine synthetase, ER/Golgi transport (Rab1B), and chro-
mobox homolog 3 participate in basic cellular activities
and reflect the relatively generalized state of naïve stem
cells. Perhaps of greater interest are those proteins known
to play a role in directing activity of non-osteogenic cell
types. For example, we identified several proteins that
have been linked with immune cell activation (e.g., car-
boxypeptidase N, SET translocation, STAT1, CamK2G).
And most interestingly, we see a number of signal trans-
duction proteins that help define undifferentiated stem
cells in our data set. For example, only unstimulated
hMSC express TRAF2 and NCK interacting kinase, which
regulates actin cytoskeletal organization [30], and TRK-
fused gene, which mediates signaling through NF-κB in
numerous cell types [31]. The most striking trend we see
is the presence of four calmodulin-dependent protein
kinase 2 isoforms in hMSC but none in hOST, consistent
with our previous suggestion that calmodulin-based sign-
aling is a potential hallmark of undifferentiated hMSC
[32]. Collectively, this expression profile supports the
notion that hMSC are more like "generic" cells than their
differentiated counterparts, though a functional defini-
tion of what constitutes a stem cell has yet to be estab-
lished [33].
At the opposite end of our axis are fully differentiated
osteoblasts. We identified 13 proteins that are expressed
in osteoblasts but not in stem cells and which our analyses
suggest contribute to the osteoblast phenotype. For some
of these proteins, the connection to osteoblast function is
fairly clear: fibronectin is expressed in the matrix of devel-
oping and mature bone and promotes the early stages of
bone formation (e.g., [34]), and vitronectin promotes
osteogenic differentiation of hMSC [13]. Several isoforms
of dihydrodiol dehydrogenase, which metabolizes pro-
gesterone, are also found in hOST, reflecting the impor-
tance of steroid hormones in skeletal growth and
maintenance [35]. Others are less obvious – e.g., superox-
ide dismutase 1 and glutathione peroxidase 1, which pro-
vide protection against oxidative stress, may serve an
important maintenance role during osteoblast differentia-
tion. Also, peroxiredoxin 5 protects cartilage cells from
oxidative stress and maintains collagen synthesis [36] –
perhaps these proteins perform a similar function during
collagen deposition by osteoblasts.
Along the middle of our axis lie the treated hMSC, and we
think that these represent intermediate states of osteo-
genic differentiation. Our analyses identified five proteins
that may distinguish these states from naïve stem cells or
osteoblasts and may uncover clues as to how osteogenic
differentiation takes place in hMSC. Interestingly, the
heavy chain of smooth muscle myosin is in this group:
recently, Discher's group demonstrated that non-muscle
myosin II mediates cell lineage specification in these cells
[10], suggesting that other myosins may play a role in
determining cell lineage specificity in response to ECM
binding. Consistent with this hypothesis, filamin A is also
found in this group. Filamin A crosslinks cortical actin fil-
aments, serves a mechanoprotective function in response
to tensile strain [37], and is controlled by calcium/cal-
modulin signaling [38]. Because calcium/calmodulin sig-
naling appears to decline during osteogenesis in hMSC,
filamin A activity may represent an early step towards lin-
eage commitment in these cells. Two other proteins that
appear in all of our cell populations (except hOST) may
also serve as markers of an intermediate state: glucose
phosphate isomerase (also known as Autocrine Motility
Factor) regulates cell growth and migration of numerous
cell types [39], and activin A receptor (type IIB) supports
growth of germ cells in the developing human embryo
[40]. As stem cells are a continually self-renewing popula-
tion, whereas osteoblasts are much less proliferative, con-
trol of growth may be a crucial step in moving away from
the stem cell phenotype.
What is especially striking is that two different protein
expression patterns occur in these intermediates: that
induced by contact with ECM proteins and that induced
by OS media. Our DCA identified three proteins that dis-
tinguish the ECM-directed route from the OS-directed
route, and all of these (two subunits of proline-4 hydrox-
ylase and lysine hydroxylase 2) are involved in collagen
synthesis and processing. These proteins are found in
hOST and all ECM-treated populations, but not in OS,
suggesting that collagen synthesis in hMSC is preferen-
tially driven by ECM contact. Consistent with this, we and
others have found that plating hMSC on collagen I stimu-
lates additional collagen synthesis [13, e.g., 41, 20]. Con-
versely, OS-treated hMSC express four proteins involved
in steroid metabolism (dihydrodiol dehydrogenase 1 and
2; 3-alpha hydroxysteroid dehydrogenase, type II; peroxi-
somal trans-2-enoyl-CoA reductase) that are not found in
ECM-treated populations. Only two of these proteins
appear in hOST. Perhaps this is not surprising, since OS
media contains the steroid analog dexamethazone, but it
illustrates an important point: hMSC can be stimulated toBMC Genomics 2007, 8:380 http://www.biomedcentral.com/1471-2164/8/380
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undergo osteogenic differentiation by two seemingly
independent routes – one driven by ECM signaling and
one by steroid hormone signaling.
Conclusion
Our three-mode tensor-based proteomic analysis, based
on gene ontologies and validated using hMSC plated on
laminin-5, has revealed two independent mechanisms by
which human mesenchymal stem cells (hMSC) undergo
osteogenic differentiation. The differences between the
proteomic profiles of OS-stimulated hMSC and ECM-
hMSC characterize different transitional phenotypes en
route to becoming osteoblasts. One of these is driven by
ECM signaling and the other by steroid hormone signal-
ing. In addition, stimulation with ECM proteins results in
a more osteoblast-like phenotype than that resulting from
stimulation with OS media. These results, arrived at
through interdisciplinary means, contribute to a better
understanding of osteogenesis and thus, we hope, eventu-
ally to improved treatment for relevant diseases and tissue
damage.
Methods
Materials
Bovine collagen I and vitronectin were purchased from
Chemicon (Temecula, CA). All other reagents and cell cul-
ture supplies were obtained as previously described
[15,16]. Protein profiles from hMSC, hMSC cultured in
OS medium, and hOST were accessed from our online
database described in [11].
Culture of hMSC
Cryopreserved hMSC were routinely passaged as previ-
ously described [11]. To collect protein expression profiles
from hMSC stimulated with ECM proteins, cells were
grown in hMSC growth media in tissue culture dishes
coated with 20 µg/ml collagen I or 20 µg/ml vitronectin,
or grown on tissue culture dishes containing laminin-5
deposited by 804G rat bladder carcinoma cells as previ-
ously described [16].
2D LC-MS/MS
Preparation of whole cell lysates (collected after 16 days in
culture) from hMSC cultured on ECM proteins for 2D LC-
MS/MS was performed as previously described [11].
Briefly, protein pellets were dissolved in 100 mM Tris-
HCl, pH 8.5, 5 mM tributyl phosphine, and 6.4 M urea.
The protein mixtures were incubated for 30 min at 37°C
followed by the alkylation in 15 mM iodoacetamide.
Reactants were then diluted six-fold and subjected to tryp-
tic digestion overnight at 37°C. The reaction was stopped
with the addition of 90% formic acid, and the resultant
peptides were then concentrated with C18 cartridges and
exchanged into 5% acetonitrile, 0.4% formic acid, and
0.005% heptafluorobutylic acid (HFBA). Samples (120 µg
protein) were analyzed in duplicate using an analytical
system consisting of a CapLC autosampler, CapLC
pumps, stream selector, Z-spray probe, and a quadruple
time-of-flight mass (TOF) spectrometer. The setup was
configured with a polysulfoethyl strong cation exchange
(SCX) column (320 µm ID X 80 mm, packed with 20 µm
POROS 20 HS from Applied Biosystems) in series with a
desalting column (300 µm ID X 5 mm, packed with a C18
stationary phase from Thermo Quest Inc.) and a reverse-
phase C18 column (75 µm ID X 110 mm, packed with
BetaBasic C18 resin from ThermoHypersil Keystone) for
two-dimensional separations. For elution, solvent A9 con-
sisted of 3% CH3CN, 0.4% acetic acid, and 0.005%
HFBA; solvent B was 90% CH3CN, 0.4% acetic acid, and
0.005% HFBA. Tryptic digests were loaded onto the 2D
LC-MS/MS system under pressure. Peptides in 10 mM
NaCl solution were first absorbed onto the SCX column;
the peptides in the flow through were washed onto the
reverse-phase peptide-trapping column where they were
concentrated and desalted. First-stage separation was
achieved by eluting the SCX column with 20 µl each of 0,
10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 120, 140, 150, 160,
200, 250, 300, 500, and 830 mM KCl. For second-stage
separation, each of the eluates was separated on a reverse-
phase column by the application of a series of mobile
phase-B gradients (1–10% B in 5 min, 10–15% B in 25
min, 15–20% B in 15 min, 20–45% B in 10 min, 45–80%
B in 5 min). The separated peptides were characterized by
their mass and sequence data (MS/MS). To load samples,
a picofrit column was connected directly to a Q-TOF 2
Zsprayer. Approximately 2,100 volts were applied to the
spray tip. Approximately 5 psi of nebulizing gas was intro-
duced around the spray tip to aid the electrospray process.
A splitter gave a resultant flow through the analytical col-
umn of 200 nl/min with the pump programmed to
deliver a flow of 6.5 µl/min. The mass spectrometer was
operated in a data-dependent acquisition mode whereby,
following the interrogation of MS data, ions were selected
for MS/MS analysis based on their intensity and charge
state. The detection threshold for this instrument is 200
pmol per protein. Collision energies were chosen auto-
matically based on the m/a and charge-state of the
selected precursor ions. Ion data were compared to the
National Center for Biotechnology Information (NCBI)
nonredundant homo sapiens database using the Proteinl-
ynx 1.1 Global Server program.
Data Preparation
945 different proteins were identified by 2D LC MS/MS;
765 different proteins were identified with accession
numbers (in Ensemble, Refseq, or Trembl format) and a
protein name. Each protein was also matched to its
GeneID at NCBI [42], if available, by accessing the Euro-
pean Bioinformatics Institute [43], downloading the
ipi.HUMAN.xrefs.gz IPI dataset [44], and matching eachBMC Genomics 2007, 8:380 http://www.biomedcentral.com/1471-2164/8/380
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accession number to its corresponding gene ID number.
Proteins that were not assigned a GeneID using this
method were searched by hand using the online search
function (IPI Quick Search) and the search feature located
at Entrez Gene by entering available accession numbers
and the protein name.
A given protein as identified by the GeneID may have
multiple accession numbers. The number of accession
numbers per protein was truncated to 2. Since laminin-5
hMSC proteomic analysis was used as validation, only
GeneIDs found in the first five samples were considered.
There are 555 such GeneIDs, corresponding to 758 pro-
teins.
To determine protein functional relationships within and
between each data set, we used the Database for Annota-
tion, Visualization and Integrated Discovery (DAVID)
[45] to annotate proteins identified by GeneID with their
gene ontologies. The GeneIDs of proteins in the six sam-
ples were categorized in Biological Process and Molecular
Function gene ontology categories using the GO Chart
feature offered by DAVID 1.0 with settings of intermediate
coverage and specificity (Level 3) with a minimum of 4
GeneIDs as done in [15,16]. The GO categories were
determined for each data set and then unioned to form a
complete list. DAVID was set at intermediate coverage and
specificity (Level 3) with a minimum of 4 GeneIDs. The
69 GO categories used in this study are given in Addi-
tional File 1.
A relational database management system (DBMS) was
used to develop both the gene ontology analysis and the
further protein classifications. Reports and queries were
written and generated, using the DBMS facilities and addi-
tional programming, to help produce the statistics
reported in this paper and to help produce the 3-dimen-
sional Proteomics Array described next.
Each entry in the three-way Proteomics Array, Xijk, repre-
sents the number of accession identifiers observed for the
ith protein available in the jth category for the kth sample.
We apply several preprocessing steps compatible with
those of two-way analysis. First, proteins that are available
in all samples and the ones that do not exist in any of the
samples are removed. The dimension of X is 361 × 69 × 5
after the elimination of these proteins. Second, each entry
is truncated to 0, 1, or 2. For the two-way model, we first
add the data across the GeneID mode to form a Sample x
Category matrix, then divide each GO vector by its sum,
and finally center the data by subtracting the hMSC vector.
For the multi-way model, we center the data with respect
to hMSC, which means that the slice or matrix corre-
sponding to hMSC is subtracted from the slices corre-
sponding to other samples. Note that as validation, the
two-way and multi-way analyses are performed using only
the first five samples and then the results for laminim-5
hMSC are projected onto the components defined by the
first five cell populations.
Two-way analysis: Directed Component Model
Consider matrix X consisting of 69 categories as rows and
5 features (experiments) as columns. Call each column xj
so that X= [x1 x2 x3 x4 x5]. Each entry Xij represents the
active proteins in category i found in experiment j. We
seek a linear model for the xj as follows:
xj = doffset + cdirected ddirected + csecond dsecond + cthird dthird + cfourth 
dfourth.
The vectors d are directions that make up the columns of
X and the scalars c are distances in these directions. Each
direction is now discussed in turn.
To begin, the first direction is the starting point for osteo-
genesis, that is, stem cells. Hence doffset =  x1, which is
hMSC. Next, we are interested in the direction that con-
nects stem cells to osteoblasts. Hence ddirected =  x5 -  x1,
which hOST less hMSC. For each experiment, cdirected is the
extent to which that experiment is similar to osteoblasts
along this route. These constants were plotted in Figure 1,
providing an implicit ranking of experiments. We see that
the three ECM-stimulated populations are closer to oste-
oblasts than are the OS media-stimulated populations.
The remaining directions {dsecond, dthird, dfourth} are chosen
such as to maximize the remaining variability subject to
being uncorrelated (perpendicular) with the previous
directions. That is, these directions are the principal com-
ponents of the remaining space. The constants thereof
{csecond, cthird, cfourth} indicate how far away from the direct
path linking stem cell to osteoblast an experiment is. The
directed component accounts for 26% of the variability
while the second, third, and fourth components account
for 41%, 22%, and 10% of the variability respectively in
the first five experiments.
Multi-way analysis: Tucker3 Model
We model the three-way Proteomics Array, X ∈ R IxJxK, as
in Equation 1, using a Tucker3 [24] model, which is one
of the most common analysis techniques in the multi-way
literature.
Here P, Q, and R indicate the number of components
extracted from the  geneID, GO and sample modes,
respectively. A ∈ R IxP, B ∈ R JxQ, and C ∈ R KxR are orthog-
onal component matrices. G ∈ R PxQxR is the core array and
XGE ijk ijk ijk =+ ∑ ∑ ∑ ABC ip jq kr
p=1
P
q=1
Q
r=1
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E ∈ R IxJxK represents the error term. A Tucker3 model with
orthogonality constraints on component matrices is also
called Higher-Order Singular Value Decomposition
(HOSVD) [46]. Figure 5 illustrates the three-way Pro-
teomics Array and how it is modeled using a Tucker3
model. In our analysis, we make use of the PLS Toolbox
[47] and for detailed information on the Tucker3 model
and other multiway analysis techniques, the reader is
referred to [48].
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